EPA (Eicosapentaenoic Acid) is the lead active here, studied most for triglycerides already in the normal range. 15 human studies on EPA (Eicosapentaenoic Acid) back this formula, each one cited. Who it fits: skews toward women, adults.
Verified by IngredientMDThe panel on the left is the one we evaluated, line by line.
All 3 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Backed by human trials".
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Cross-checked against 246 documented interactions for these actives.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
89% of US adults
aged 19 and over consumed more than the recommended 2,300 milligrams of sodium a day, in a CDC analysis of 2009 to 2012 dietary survey data.
CDC Morbidity and Mortality Weekly Report, 201457.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health Statistics65.5% of US adults aged 20 to 64
had a blood cholesterol check by a health professional in the past 12 months in 2017, up from 58.0% in 2012, in the National Health Interview Survey.
CDC National Center for Health Statistics, 2019Fewer than 1 in 5 US adults
know their cholesterol or blood sugar numbers, according to a national survey fielded for The Ohio State University Wexner Medical Center in December 2023.
SSRS Opinion Panel Omnibus for The Ohio State University Wexner Medical Center, 20239% of US women
and 5% of US men are getting the recommended daily amount of dietary fibre, based on National Health and Nutrition Examination Survey data collected from 2013 to 2018.
American Society for Nutrition, 202159 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Meta-analysis, 2022
Across 71 randomised trials in 4,973 adults, a combined EPA plus DHA intake of 2 to 3 g a day lowered systolic blood pressure by about 2.6 mmHg and diastolic by about 1.6 to 1.8 mmHg.
Journal of the American Heart AssociationMeta-analysis, 2023
In women after midlife, omega-3 supplementation lowered blood triglycerides by about 17.8 mg/dL, with a larger drop of about 21 mg/dL at doses of 1 g a day or more, while LDL and HDL cholesterol rose slightly and total cholesterol was unchanged.
Clinical TherapeuticsMeta-analysis, 2021
Across 33 trials, DHA lowered blood triglycerides and raised HDL cholesterol by about 0.07 mmol/L, but also raised LDL cholesterol by about 0.26 mmol/L.
Clinical NutritionMeta-analysis, 2024
A meta-analysis of 53 trials in 171,668 people found omega-3 lowered a marker of inflammation by about 0.27 mg/L, and the drop did not track changes in LDL cholesterol.
Cardiovascular ResearchMeta-analysis, 2026
Pooled trials looked at omega-3s against inflammation markers and recovery measures in sport, with omega-6 relevance only indirect through shared pathways.
FASEB journalMeta-analysis, 2020
Across trials in older adults with mild memory complaints, DHA was linked to better memory test scores, though no difference was detected in those without complaints, which does not mean none exists.
European journal of clinical pharmacologyMeta-analysis, 2026
Pooling high-dose EPA trials, the authors report that observed cardiovascular outcomes differed by the formulation studied rather than being uniform across preparations.
American Journal of Cardiovascular DrugsMeta-analysis, 2022
Across trials, EPA lowered LDL cholesterol about 8.5 mg/L more than DHA, while the two acted much alike on the other markers measured.
Nutrition, Metabolism and Cardiovascular DiseasesMeta-analysis, 2026
Pooled trials found that the EPA to DHA ratio of a supplement shapes which fatty acids rise in the blood, with higher EPA shares linked to larger falls in circulating inflammatory markers, which are blood measures rather than outcomes.
Critical reviews in food science and nutritionSystematic review, 2025
The review found that supplementation raised blood DHA status in people following a long-term protein-restricted diet, with the authors describing the functional outcome evidence as limited.
Frontiers in NutritionMeta-analysis, 2020
Across 12 trials, omega-3 eased muscle soreness two days after hard exercise by about 0.93 points on a 10-point scale, below what people notice, with strength and flexibility unchanged.
BioMed Research InternationalMeta-analysis, 2019
Increasing omega-3, omega-6 or total polyunsaturated fat intake made little to no difference to blood sugar control measures such as HbA1c in adults.
Meta-analysisMeta-analysis, 2021
In head to head and network comparisons of 20 randomised trials, EPA and DHA moved C-reactive protein, interleukin-6 and TNF-alpha to a similar degree, with no difference detected between the two.
Advances in NutritionMeta-analysis, 2026
A pooled analysis of trials of combined EPA and DHA supplementation reporting change in itch severity scores, a patient-reported measure.
PharmaceuticalsMeta-analysis, 2018
Pooling long term trials, increasing polyunsaturated fat intake made little or no difference to death from any cause, and the effect on other outcomes stayed uncertain.
The Cochrane database of systematic reviewsMeta-analysis, 2026
Pooling trials of DHA taken during pregnancy, the review found only small and inconsistent differences in later child neurodevelopmental scores.
Developmental psychobiologyRandomised trial, 2025
Taking DHA through pregnancy and early lactation raised the DHA content of breast milk compared with control.
Randomised trialMeta-analysis, 2024
Across nine randomised trials, 450 to 800 mg a day of DHA in the second half of pregnancy was linked to infant birth weight about 102 g higher, with no difference detected in gestation length.
Nutrition ResearchPopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
In a randomised single-blind trial, 20 participants took either fish oil supplying 1,296 mg EPA and 864 mg DHA daily or flaxseed oil for eight weeks, with erythrocyte membrane and plasma samples drawn at weeks 0, 4, 8, 10, 12, 14, 16 and 24. On fish oil, erythrocyte membrane EPA rose 300 percent and DHA rose 42 percent by week eight. Levels held until about week 12 and then declined across the post-supplementation sampling, faster in plasma phospholipids than in erythrocyte membranes. Membrane fatty acid content was measured, not a symptom, and this is one trial of 20 people.
In the trial record, EPA in blood plasma plateaus after 4 to 8 weeks of daily fish oil, while EPA in the red blood cell membrane rises with a 28 day half-life and reaches a steady state at about 180 days.
In a randomised double-blind crossover trial, healthy men and women aged 19 to 34 took capsules supplying about 4 g DHA per day, with plasma sampled at days 0, 1, 3, 7, 14 and 28. DHA concentrations tripled and so did DHA-derived oxylipins. Increases were detectable as early as day 1, and 11 of 12 individual DHA oxylipins plus total DHA oxylipins reached a plateau by days 5 to 7. The plateau came earlier and was reached by more oxylipins in females than in males. Plasma marker chemistry was measured, not a feeling.
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
Three ingredients, from each one's own page.
Red cell membranes turn over slowly, so an omega-3 index climbs over eight to twelve weeks. Triglyceride changes read out on a panel around week four to eight.
EPA has to work its way into cell membranes, and an omega 3 index blood test picks up most of the change by weeks eight to twelve of daily use.
Red blood cell omega-3 levels climb over roughly eight to twelve weeks of steady daily intake. That is where the change shows up, on a fatty acid panel rather than as a sensation.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
It is a softgel, so the active is already dissolved in oil and the shell keeps it away from air and light.
Because the effect builds and holds only with continued daily use, a steady recurring supply is the practical way to keep it going.
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.
